Acquired ALK Resistance Mutations Identified from Liquid Biopsy in an ALK-Rearranged Squamous Cell Lung Cancer Patient Treated with Sequential ALK TKI Therapy: A Case Report

Acquired ALK Resistance Mutations Identified from Liquid Biopsy in an ALK-Rearranged Squamous Cell Lung Cancer Patient Treated with Sequential ALK TKI Therapy: A Case Report

Bin Yao,1 Xue Han,2 Linrong Pang,1 Caihong Xu,1 Sisi Liu,2 Xiaochun Cheng,1 Jun Chen1 1Department of Radiotherapy and Chemotherapy, The Affiliated People’s Hospital of Ningbo University, Ningbo, Zhejiang, People’s Republic of China; 2Department of Research and Development, Nanjing Geneseeq Technolog...

Full description

Bibliographic Details
Main Authors: Yao B, Han X, Pang L, Xu C, Liu S, Cheng X, Chen J
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:OncoTargets and Therapy
Subjects:
alk rearrangement
dynamic monitoring
resistance mutation
next-generation sequencing
Online Access:https://www.dovepress.com/acquired-alk-resistance-mutations-identified-from-liquid-biopsy-in-an--peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/acquired-alk-resistance-mutations-identified-from-liquid-biopsy-in-an--peer-reviewed-fulltext-article-OTT

Similar Items